{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:52:12Z","timestamp":1770976332479,"version":"3.50.1"},"reference-count":40,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union-NextGenerationEU","award":["BG-RRP-2.004-0004-C01"],"award-info":[{"award-number":["BG-RRP-2.004-0004-C01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>In the current study, chromatographic and in silico techniques were applied to investigate the biotransformation of ethyl 5-(4-bromophenyl)-1-(2-(2-(2-hydroxybenzylidene) hydrazinyl)-2-oxoethyl)-2-methyl-1H-pyrrole-3-carboxylate (11b) in hepatocytic media. The initial chromatographic procedure was based on the employment of the conventional octadecyl stationary phase method for estimation of the chemical stability. Subsequently, a novel and rapid chromatographic approach based on a phenyl\u2013hexyl column was developed, aiming to separate the possible metabolites. Both methods were performed on a Dionex 3000 ThermoScientific (ACM 2, Sofia, Bulgaria) device equipped with a diode array detector set up at 272 and 279 nm for analytes detection. An acetonitrile: phosphate buffer of pH 3.5: methanol (17:30:53 v\/v\/v) was eluted isocratically as a mobile phase with a 1 mL\/min flow rate. A preliminary purification from the biological media was achieved by protein precipitation with methanol. A validation procedure was carried out, where the method was found to correspond to all ICH (Q2) and M10 set criteria. Additionally, an in silico-based approach with the online server BioTransformer 3.0 was applied in an attempt to predict the possible metabolites of the title compound 11b. It was hypothesized that four CYP450 isoforms (1A2, 2C9, 3A4, and 2C8) were involved in the phase I metabolism, resulting in the formation of 12 metabolites. Moreover, docking studies were conducted to evaluate the formation of stable complexes between 11b and the aforementioned isoforms. The obtained data indicated three metabolites as the most probable products, two of which (M9_11b and M10_11b) were synthesized by a classical approach for verification. Finally, liquid chromatography with a mass detector was implemented for comprehensive and summarized analysis, and the obtained results revealed that the metabolism of the 11b proceeds possibly with the formation of glucuronide and glycine conjugate of M11_11b.<\/jats:p>","DOI":"10.3390\/molecules29071474","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T11:05:33Z","timestamp":1711451133000},"page":"1474","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In Silico and Chromatographic Methods for Analysis of Biotransformation of Prospective Neuroprotective Pyrrole-Based Hydrazone in Isolated Rat Hepatocytes"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1905-7130","authenticated-orcid":false,"given":"Alexandrina","family":"Mateeva","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University\u2014Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Kondeva-Burdina","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Pharmacotherapy, Faculty of Pharmacy, Medical University\u2014Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-7213","authenticated-orcid":false,"given":"Emilio","family":"Mateev","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University\u2014Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5640-6120","authenticated-orcid":false,"given":"Paraskev","family":"Nedialkov","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Medical University\u2014Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Lyubomirova","sequence":"additional","affiliation":[{"name":"Department of Occupational Medicine, Faculty of Public Health, Medical University\u2014Sofia, 8 Bjalo More Str., 1527 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Peikova","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University\u2014Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Georgieva","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University\u2014Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1695-8454","authenticated-orcid":false,"given":"Alexander","family":"Zlatkov","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University\u2014Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/12081910","article-title":"Biological activities of hydrazone derivatives","volume":"12","author":"Rollas","year":"2007","journal-title":"Molecules"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jps.3030430902","article-title":"Isonicotinyl hydrazones as antitubercular agents and derivatives for idendification of aldehydes and ketones","volume":"43","author":"Sah","year":"1954","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.2042-7158.1952.tb13218.x","article-title":"Some further studies on tuberculostatic compounds","volume":"4","author":"Bavin","year":"1954","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_4","first-page":"526","article-title":"Sravnenie farmakologichesko\u012d aktivnosti i toksichnosti antidepressantov nialamida, fenelzina i iproniazida [Comparison of pharmacological activity and toxicity of the antidepressants nialamide, phenelzine and iproniazide]","volume":"32","author":"Lapin","year":"1969","journal-title":"Farmakol Toksikol."},{"key":"ref_5","first-page":"179","article-title":"Chapter Six\u2014Neuroprotective natural products","volume":"55","author":"Das","year":"2020","journal-title":"Annu. Rep. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1570159X16666180911124605","article-title":"Neuroprotective Strategies for Neurological Disorders by Natural Products: An update","volume":"17","author":"Rehman","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0192623307310947","article-title":"Metabolic profiling as a tool for understanding mechanisms of toxicity","volume":"36","author":"Clarke","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2116\/analsci.19R002","article-title":"An Exploration of Advancement in Analytical Methodology for Quantification of Anticancer Drugs in Biomatrices","volume":"35","author":"Jain","year":"2019","journal-title":"Anal. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zeki, \u00d6.C., Eylem, C.C., Re\u00e7ber, T., K\u0131r, S., and Nemutlu, E. (2020). Integration of GC-MS and LC-MS for untargeted metabolomics profiling. J. Pharm. Biomed. Anal., 190.","DOI":"10.1016\/j.jpba.2020.113509"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.forsciint.2009.04.001","article-title":"Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine","volume":"188","author":"Zaitsu","year":"2009","journal-title":"Forensic Sci. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trac.2011.08.009","article-title":"Metabolite identification and quantitation in LC-MS\/MS-based metabolomics","volume":"32","author":"Xiao","year":"2012","journal-title":"Trends Anal. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kondeva-Burdina, M., Mateev, E., Angelov, B., Tzankova, V., and Georgieva, M. (2022). In Silico Evaluation and In Vitro Determination of Neuroprotective and MAO-B Inhibitory Effects of Pyrrole-Based Hydrazones: A Therapeutic Approach to Parkinson\u2019s Disease. Molecules, 27.","DOI":"10.3390\/molecules27238485"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tzankova, D., Kuteva, H., Mateev, E., Stefanova, D., Dzhemadan, A., Yordanov, Y., Mateeva, A., Tzankova, V., Kondeva-Burdina, M., and Zlatkov, A. (2023). Synthesis, DFT Study, and In Vitro Evaluation of Antioxidant Properties and Cytotoxic and Cytoprotective Effects of New Hydrazones on SH-SY5Y Neuroblastoma Cell Lines. Pharmaceuticals, 16.","DOI":"10.3390\/ph16091198"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.31925\/farmacia.2022.2.21","article-title":"Design, synthesis, biological evaluation and molecular docking of pyrrole-based compounds as antioxidant and MAO-B inhibitory agents","volume":"70","author":"Mateev","year":"2022","journal-title":"Farmacia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/livers3030032","article-title":"Perspective on Quantitative Structure\u2013Toxicity Relationship (QSTR) Models to Predict Hepatic Biotransformation of Xenobiotics","volume":"3","author":"Rai","year":"2023","journal-title":"Livers"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Hlengwa, N., Masilela, C., Mtambo, T.R., Sithole, S., Naidoo, S., Machaba, K.E., Shabalala, S.C., Ntamo, Y., Dludla, P.V., and Milase, R.N. (2023). In Vitro Hepatic Models to Assess Herb\u2013Drug Interactions: Approaches and Challenges. Pharmaceuticals, 16.","DOI":"10.3390\/ph16030409"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10337-023-04260-5","article-title":"Development of Hyphenated Techniques and Network Identification Approaches for Biotransformational Evaluation of Promising Antitubercular N-pyrrolyl hydrazide-hydrazone in Isolated Rat Hepatocytes","volume":"86","author":"Mateeva","year":"2023","journal-title":"Chromatographia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jssc.200900742","article-title":"HILIC methods in pharmaceutical analysis","volume":"33","author":"Dejaegher","year":"2010","journal-title":"J. Sep. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Bieke, D., Liu, Q., Cai, J., Nichols, R.G., Tian, Y., Zhang, J., Smith, P.B., Wang, Y., Yan, C., and Patterson, A.D. (2019). A Quantitative HILIC-MS\/MS Assay of the Metabolic Response of Huh-7 Cells Exposed to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin. Metabolites, 9.","DOI":"10.3390\/metabo9060118"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4939-7643-0_5","article-title":"HILIC-MS\/MS Multi-Targeted Method for Metabolomics Applications","volume":"1738","author":"Virgiliou","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.aca.2009.01.054","article-title":"Analysis of highly polar metabolites in human plasma by ultra-performance hydrophilic interaction liquid chromatography coupled with quadrupole-time of flight mass spectrometry","volume":"650","author":"Cai","year":"2009","journal-title":"Anal. Chim. Acta"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00216-011-5308-5","article-title":"Hydrophilic interaction liquid chromatography (HILIC)--a powerful separation technique","volume":"402","author":"Buszewski","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/chromsci\/bmu093","article-title":"Comparison of chromatographic conditions for analysis of selected psychotropic drugs in human serum","volume":"53","author":"Petruczynik","year":"2015","journal-title":"J. Chromatogr. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchromb.2017.05.033","article-title":"Application of phenyl-based stationary phases for the study of retention and separation of oligonucleotides","volume":"1060","author":"Bocian","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chang, Y., Hawkins, B.A., Du, J.J., Groundwater, P.W., Hibbs, D.E., and Lai, F. (2022). A Guide to In Silico Drug Design. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010049"},{"key":"ref_26","first-page":"89","article-title":"Modern drug discovery process: An in silico approach","volume":"2","author":"Rao","year":"2011","journal-title":"J. Bioinform. Seq. Analysis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fphar.2019.00434","article-title":"In silico ADME and Toxicity Prediction of Ceftazidime and Its Impurities","volume":"10","author":"Han","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fchem.2020.00726","article-title":"Computational Approaches in Preclinical Studies on Drug Discovery and Development","volume":"8","author":"Wu","year":"2020","journal-title":"Front. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/cbdd.13445","article-title":"Computational methods and tools to predict cytochrome P450 metabolism for drug discovery","volume":"93","author":"Tyzack","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Yim, S.K., Kim, K., Chun, S., Oh, T., Jung, W., Jung, K., and Yun, C.H. (2020). Screening of Human CYP1A2 and CYP3A4 Inhibitors from Seaweed In Silico and In Vitro. Mar. Drugs, 18.","DOI":"10.3390\/md18120603"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcatb.2010.01.017","article-title":"Oxidation of human cytochrome P450 1A2 substrates by Bacillus megaterium cytochrome P450 BM3","volume":"63","author":"Kim","year":"2010","journal-title":"J. Mol. Catal. B Enzym."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3897\/pharmacia.69.e96626","article-title":"In vitro effects and in silico analysis of newly synthetized pyrrole derivatives on the activity of different isoforms of Cytochrome P450: CYP1A2, CYP2D6 and CYP3A4","volume":"69","author":"Angelov","year":"2022","journal-title":"Pharmacia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2174\/157018010791306588","article-title":"Pyrrole-based hydrazones synthesized and evaluated in vitro as potential tuberculostatics","volume":"7","author":"Bijev","year":"2010","journal-title":"Lett. Drug Des. Discov."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.trac.2008.01.008","article-title":"LC-MS-based methodology for global metabolite profiling in metabonomics\/metabolomics","volume":"27","author":"Theodoridis","year":"2008","journal-title":"TrAC Trends Anal. Chem."},{"key":"ref_35","first-page":"69","article-title":"Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes","volume":"263","author":"Fau","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"14348","DOI":"10.1074\/jbc.M611692200","article-title":"Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2","volume":"282","author":"Sansen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"17227","DOI":"10.1074\/jbc.M802180200","article-title":"Determinants of cytochrome P450 2C8 substrate binding: Structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid","volume":"283","author":"Schoch","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1074\/jbc.M114.627661","article-title":"Contributions of ionic interactions and protein dynamics to cytochrome P450 2D6 (CYP2D6) substrate and inhibitor binding","volume":"290","author":"Wang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13682","DOI":"10.1073\/pnas.0603236103","article-title":"Structural basis for ligand promiscuity in cytochrome P450 3A4","volume":"103","author":"Ekroos","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.phymed.2012.09.021","article-title":"Enzyme kinetic and molecular docking studies for the inhibitions of miltirone on major human cytochrome P450 isozymes","volume":"20","author":"Zhou","year":"2013","journal-title":"Phytomedicine"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/7\/1474\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:18:58Z","timestamp":1760105938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/7\/1474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["molecules29071474"],"URL":"https:\/\/doi.org\/10.3390\/molecules29071474","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}